clinical trial · NCT06836037
A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011)
Merck Sharp & Dohme LLC·phase1·completed·n = 56
HealthyEfinopegdutidePlacebo
brief summary
The goal of this study is to learn about the safety and whether people tolerate a study medicine called efinopegdutide. The study will also measure what happens to efinopegdutide in a healthy person's body over time.
started
Sep 5, 2022
primary completion
Feb 2, 2023
completion
Feb 2, 2023
last updated
Feb 21, 2025
official title
A Single and Multiple Dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics of MK-6024 in Healthy Chinese Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol